Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?

被引:28
作者
Berg, T
Gerlach, T
Sarrazin, C
Zachoval, R
Buggisch, P
Zeuzem, S
机构
[1] Charite Univ Med Berlin, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany
[2] Univ Munich, Klinikum Grosshadern, Med Klin 2, D-8000 Munich, Germany
[3] Univ Hamburg, Klin Eppendorf, Med Kernklin Gastroenterol, Hamburg, Germany
[4] Univ Kiel, Med Klin 1, Klin Allgemeine Innere Med, Kiel, Germany
[5] Univ Saarlandes Kliniken, Med Klin & Poliklin Innere Med 2, Homburg, Germany
关键词
D O I
10.1002/hep.20226
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1456 / 1457
页数:2
相关论文
共 7 条
[1]   Sampling variability of liver fibrosis in chronic hepatitis C [J].
Bedossa, P ;
Dargère, D ;
Paradis, V .
HEPATOLOGY, 2003, 38 (06) :1449-1457
[2]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[3]   Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model [J].
Forns, X ;
Ampurdanès, S ;
Llovet, JM ;
Aponte, J ;
Quintó, L ;
Martínez-Bauer, E ;
Bruguera, M ;
Sánchez-Tapias, JM ;
Rodés, J .
HEPATOLOGY, 2002, 36 (04) :986-992
[4]   Noninvasive diagnosis of fibrosis: The truth is rarely pure and never simple [J].
Giannini, E ;
Testa, R .
HEPATOLOGY, 2003, 38 (05) :1312-1313
[5]   Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study [J].
Imbert-Bismut, F ;
Ratziu, V ;
Pieroni, L ;
Charlotte, F ;
Benhamou, Y ;
Poynard, T .
LANCET, 2001, 357 (9262) :1069-1075
[6]   Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin [J].
Poynard, T ;
McHutchison, J ;
Manns, M ;
Myers, RP ;
Albrecht, J .
HEPATOLOGY, 2003, 38 (02) :481-492
[7]   A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C [J].
Wai, CT ;
Greenson, JK ;
Fontana, RJ ;
Kalbfleisch, JD ;
Marrero, JA ;
Conjeevaram, HS ;
Lok, ASF .
HEPATOLOGY, 2003, 38 (02) :518-526